News

AI, Google

Human trials for Google’s drugs made by AI set to begin soon, possibly changing how we perceive healthcare
Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial intelligence. (Unsplash) Google DeepMind's somewhat secretive spinoff, Isomorphic Labs,
AI-powered drug company spun out of Google’s DeepMind says human trials are ‘very close’
Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. In an interview with Fortune on July 6, Colin Murdoch, Isomorphic Labs ...
Google-backed Isomorphic Labs to launch human trials for AI-designed drugs
Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.
Alphabet’s Isomorphic Labs has grand ambitions to ‘solve all diseases’ with AI. Now, it’s gearing up for its first human trials
One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to address that disease,” Colin Murdoch, Isomorphic Labs president and Google DeepMind's chief business officer said.
Google DeepMind ready to start human trials of AI-designed drugs; company exec says, ‘We’re getting very close’
Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in pharmaceutical innovation.
Google’s Secret Moonshot Project Gears Up For Human Trail Of AI-Designed Drugs
Google DeepMind's moonshot, Isomorphic Labs, is gearing up to launch its first ever human trial of AI-designed drugs. The hitherto lesser-known Google subsidiary aims to revolutionize drug development by using advanced AI to create medicines more quickly, affordably, and accurately than traditional methods.
Google’s AI-designed drugs to enter human trials this year
Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling breakthroughs.
Google’s Isomorphic Labs “Very Close” To Starting Human Trials For AI-Generated Medicines
Google DeepMind CEO Demis Hassabis has said that AI can have a serious crack at solving all diseases in the coming years. And his company is on track to put these words into practice. Isomorphic Labs,
Google DeepMind to soon begin human trials of AI-designed drugs
Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a significant leap in pharmaceutical innovation.
Google Ready To Start Human Trials Of Its AI-Designed Drugs
Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.
An AI That Promises to “Solve All Diseases” Is About to Test Its First Human Drugs
A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...
Research Snipers19h
Google daughter wants to heal “all diseases” with AI
Google Deepmind’s offshoot Isomorphic Labs is about to be a milestone: The first AI developed medication should go into the ...
Alphabet-Backed Drug Discovery Firm Nears Human Trials Of AI-Developed Remedies, Says President: 'The Next Big Milestone Is…'
Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...